PMAC at SABCS 2025

We are excited to share that PMAC will be present at the San Antonio Breast Cancer Symposium (SABCS) 2025 with several impactful presentations. Connect with us at SABCS 2025 and share insights on advancing breast cancer research.

Poster Spotlight 5

📍 December 11, 2025 | 7:00 AM–8:30 AM | Hemisfair 3

• PD5-05: Impact of circulating tumor DNA (ctDNA) surveillance on quality of life (QoL) for patients with early-stage breast cancer (EBC): prospective I-SURV study

  Presenter: Cheng Cheng, University of California, Los Angeles, CA

  
  

Poster Session 2

📍 December 10, 2025 | 5:00 PM – 6:30 PM | Exhibit Hall

• PS2-07-04: Time-to-progression patterns during first and second-line endocrine therapy across clinical features and liquid biopsy-defined mutational profiles in HR+/HER2- metastatic breast cancer

  Presenter: Lorenzo Gerratana, University of Udine, Udine, Italy

  
  

• PS2-09-18: Real-time liquid biopsy assessment in early-stage breast cancer: methylation-based ctDNA analysis and CTCs detection as potential predictors of response to neoadjuvant therapy

  Presenter: Caterina Gianni, Insituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

  
  

• PS2-10-11: Evaluating the impact of neighborhood deprivation on CDK4/6 inhibitor use, outcomes, and circulating tumor DNA (ctDNA) alterations in patients with metastatic breast cancer

• Presenter: Emily Podany, Washington University in St Louis, St Louis, MO

Poster Session 4

📍 December 11, 2025 | 5:00 PM – 6:30 PM | Exhibit Hall

• PS4-02-11: Molecular and prognostic profiling of HR+/HER2+ Metastatic Breast Cancer (MBC): insights from circulating tumor DNA (ctDNA)-based genomic analysis

  Presenter: Lorenzo Foffano, University of Udine, Udine, Italy

  
  

• PS4-03-26: Cell-free DNA BRCA copy number loss and/or deletions in patients with metastatic breast cancer: incidence and association with clinical and genomic features

  Presenter: Neelima Vidula, Massachusetts General Hospital, Boston, MA